Earnings Watch: Will investors be flying blind after Q1 earnings? Earnings Watch: Will investors be flying blind after Q1 earnings? Earnings Watch: Will investors be flying blind after Q1 earnings?

Earnings Watch: Will investors be flying blind after Q1 earnings?

Equities 3 minutes to read
Peter Garnry

Chief Investment Strategist

Summary:  Equities have been rallying and with the earnings season firing up market sentiment will be tested. The big question is whether investors will get outlooks from companies in order to navigate the equity market as expectations are important for valuation and thus future returns.


The Q1 earnings season starts today with JPMorgan Chase, Wells Fargo and Johnson & Johnson reporting earnings. For more regional flavour on US banking earnings First Republic Bank is also reporting earnings. Our focus today will be on Wells Fargo as the bank is far more main street compared to JPMorgan Chase that will do well due to solid activity in its capital market division. Wells Fargo is expected to see Q1 EPS drop by 47% compared to same period last year. But more importantly investors are hungry for outlooks.

Very few companies have made any guidance in March and many companies are scrapping their guidance for this year as they have very low visibility. And here lies the danger for the buoyant equity market. If no outlook is provided how are investors able to navigate equity markets and future profitability which leads into valuation that drives future returns?

Yesterday we published an update to our dividend model on S&P 500 based on Dec 2021 Dividend Futures which is the only liquid market we have on future profitability. Based on historic ranges of dividend yield, earnings yield and payout ratio we estimate that the S&P 500 has a 20% downside risk from current levels. In other words, sentiment is too optimistic against fundamentals.

Other important earnings releases this week are.

Wed: Citigroup, Charles Schwab, Poly Developments & Holdings, ASML, Bank of America, PNC Financial Services, Goldman Sachs, UnitedHealth, US Bancorp

Thu: TSMC, Intuitive Surgical, Bank of New York Mellon, Abbott Laboratories, BlackRock

Fri: Danaher, Honeywell, Morgan Stanley, Jiangsi Hengrui Medicine, Las Vegas Sands, East Money, Schlumberger, State Street

The recent rally in equities has been led by technology companies so this also the most important battleground in this earnings season. Investors seem to be betting on technology and online companies to fly through this global pandemic with little scars to show for. We are not buying that thesis but we may be proven wrong when technology companies are reporting earnings in the coming weeks. We believe Apple, Alphabet and Facebook are vulnerable to the slowdown in consumer and advertising spending.

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 05

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.